Trial intelligence / Profile preview

Immune response to primary tick-borne encephalitis vaccination in older versus younger adults

2007-005645-38Phase 4Completed

Sponsor
Clinical Institute of Virology
Start
Jan 2008
Modality
Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 4, open-label trial of FSME-IMMUN in tick-borne encephalitis (TBE) (2 arms), sponsored by Clinical Institute of Virology. Started Jan 2008; status: completed.

02

Drugs

FSME-IMMUN
03

Conditions

tick-borne encephalitis (TBE)

Beyond the preview

Go deeper on 2007-005645-38.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-005645-38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call